Abstract
Urban water cycles are threatened in many ways by human activities, including the discharge of chemicals by industrial and household effluents. Since more than a decade it has been recognised that the active ingredients of human pharmaceuticals contribute to the chemical contamination of urban surface waters and may pose a serious risk to the environment. Pharmaceuticals reach the aquatic environment due to their everyday use, excretion by humans and incomplete degradation in sewage treatment works. Their environmental concentrations are generally low. Due to their biologic activity, however, pharmaceuticals are considered as candidate compounds for low-level and chronic effects. Indeed, some pharmaceuticals, such as compounds interfering with reproductive hormones, provoke long-term effects on aquatic vertebrates in the ng/L range. Therefore, appropriate regulations for the environmental risk assessment as part of the approval of new medicines have been established. It was criticised, however, that these guidelines would not have been able to detect or predict the effects of some compounds with already known environmental impact. Thus, approaches for amending existing guidelines have been suggested. In this review, we give a brief overview on current and novel approaches for the prospective environmental risk assessment of human pharmaceuticals in the aquatic environment. In particular, we compare different strategies to identify potential ecotoxic effects and the possible applications within a regulatory framework. We indicate a number of tools that could improve the detection of compounds with potential low-level effects or hitherto unknown but relevant alternative mode of actions with implications for long-term effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahlers, J., Riedhammer, C., Vogliano, M., Ebert, R.-U., Kuhne, R., & Schuurmann, G. (2006). Acute to chronic ratios in aquatic toxicity-variation across trophic levels and relationship with chemical structure. Environmental Toxicology and Chemistry, 25, 2937-2945.
Alder, A. C., Bruchet, A., Carballa, M., Clara, M., Joss, A., Löffler, D., et al. (2006). Consumption and occurence. In: T. Ternes (Ed.), Human pharmaceuticals, hormones and fragrances: The challenge of micropollutants in urban water management (pp. 15-54). London: IWA Publishing.
Ankley, G., Black, M., Garric, J., Hutchinson, T., & Iguchi, T. (Eds.) (2005). A framework for assessing the hazard of pharmaceutical materials to aquatic species. In R. T. Williams (Ed.), Human pharmaceuticals: Assessing the impacts on aquatic ecosystems (pp. 183-238). Pensacola: SETAC.
Ankley, G. T., Daston, G. P., Degitz, S. J., Denslow, N. D., Hoke, R. A., Kennedy, S. W., et al. (2006). Toxicogenomics in regulatory ecotoxicology. Environmental Science and Technology, 40, 4055-4065.
Bartels, P., & von Tümpling, J. W. (2007). Solar radiation influence on the decomposition process of diclofenac in surface waters. The Science of the Total Environment, 374, 143-155.
Bound, J. P., & Voulvoulis, N. (2004). Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies. Chemosphere, 56, 1143-1155.
Cunningham, V., Buzby, M., Hutchinson, T., Mastrocco, F., Parke, N., & Roden, N. (2006). Effects of human pharmaceuticals on aquatic life: Next steps. Environmental Science and Technology, 40, 3456-3462.
Daughton, C. G., & Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107(Suppl 6), 907-938.
Ellis, J. B. (2006). Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environmental Pollution, 144, 184-189.
EMEA. (2007). Overview of comments received on guideline on environmental impact assessment for veterinary medicinal products (in support of the VICH guidelines GL6 and GL38). EMEA/CVMP/346335/2006.
EMEA/CHMP. (2006). Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00. From http://www.emea.europa.eu1.
EPA. (2003). Draft detailed review paper on a fish two-generation toxicity test. EPA contract number 68-W-01-023 work assignment 2-13 (Prepared under WA 3-5, Task 3). From http://www.oecd.org/dataoecd/13/4/2497858.pdf.
Escher, B. I., Bramaz, N., Eggen, R. I. L., & Richter, M. (2005). In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environmental Science and Technology, 39, 3090-3100.
Escher, B. I., Bramaz, N., Richter, M., & Lienert, J. (2006). Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environmental Science and Technololgy, 40, 7402-7408.
FDA. (1998). Guidance for industry - environmental assessment of human drug and biologics applications. US Department of Health and Human Services, Food and Drug Administration, CMC6, revision 1. From http://www.fda.gov/cder/guidance/index.htm.
Fent, K. (2008). Effects of pharmaceuticals on aquatic organisms. In K. Kümmer (Ed.), Pharmaceuticals in the environment - sources, fate, effects and risks (pp. 175-203). Berlin: Springer.
Fleming, A. (2007). Zebrafish as an alternative model organism for disease modelling and drug discovery: Implications for the 3Rs. NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in research), 10, 1-7. From http://www.nc3rs.org.uk1.
Garric, J., Vollat, B., Duis, K., Péry, A., Junker, T., Ramil, M., et al. (2007). Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere, 69, 903-910.
Gunnarsson, L., Jauhiainen, A., Kristiansson, E., Nerman, O., & Larsson, D. G. J. (2008). Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environmental Science and Technology, 42, 5807-5813.
Heberer, T. (2002a). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicology Letters, 131, 5-17.
Heberer, T. (2002b). Tracking persistent pharmaceutical residues from municipal sewage to drinking water. Journal of Hydrology, 266, 175-189.
Heckmann, L., Sibly, R., Connon, R., Hooper, H., Hutchinson, T., Maund, S., et al. (2008). Systems biology meets stress ecology: Linking molecular and organismal stress responses in Daphnia magna. Genome Biology, 9, R40.
Hoeger, B., Köllner, B., Dietrich, D. R., & Hitzfeld, B. (2005). Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquatic Toxicology, 75, 53-64.
Huggett, D., Benson, W., Chipman, K., Cook, J., Gray, L., Kinter, L., et al. (2005). Role of mammalian data in determining pharmaceutical responses in aquatic species. In: R. T. Williams (Ed.), Human pharmaceuticals assessing the impacts on aquatic ecosystems (pp. 149-181). Pensacola: SETAC.
Huggett, D. B., Cook, J. C., Ericson, J. F., & Williams, R. T. (2003). A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Human and Ecological Risk Assessment, 9, 1789-1799.
Hutchinson, T. H., Ankley, G. T., Segner, H., & Tyler, C. R. (2006). Screening and testing for endocrine disruption in fish-biomarkers as “signposts,” not “traffic lights,” in risk assessment. Environmental Health Perspectives, 114(Suppl 1), 106-114.
Jones, O. A. H., Voulvoulis, N., & Lester, J. N. (2002). Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research, 36, 5013-5022.
Kidd, K. A., Blanchfield, P. J., Mills, K. H., Palace, V. P., Evans, R. E., Lazorchak, J. M., et al. (2007). Collapse of a fish population after exposure to a synthetic estrogen. Proceedings of the National Academy of Sciences of the United States of America, 104, 8897-8901.
Knacker, T., Liebig, M., & Moltmann, J. F. (2006). Environmental risk assessment. In T. Ternes & A. Joss (Eds.), Human pharmaceuticals, hormones and fragrances - the challenge of micropollutants in urban water management (pp. 121-148). London: IWA Publishing.
Koschorreck, J., & Apel, P. (2006). A brief overview on the legal background and the regulatory instruments of the environmental risk assessment for pharmaceuticals in the EU, USA, Japan, Australia and Canada. In T. Ternes & A. Joss (Eds.), Human pharmaceuticals, hormones and fragrances: The challenge of micropollutants in urban water management (pp. 107-120). London: IWA Publishing.
Lange, R., & Dietrich, D. (2002). Environmental risk assessment of pharmaceutical drug substances - conceptual considerations. Toxicology Letters, 131, 97-104.
Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., Rideout, B. A., et al. (2004). Diclofenac residues as the cause of vulture population decline in Pakistan. Nature, 427, 630-633.
OECD 201. (1984). OECD guideline for testing of chemical: Alga, growth inhibition test. From http://www.oecd.org/dataoecd/.
OECD 211. (1998). OECD guidelines for testing of chemicals: Daphnia magna reproduction test. From http://www.oecd.org/dataoecd/.
OECD. (2006). Report of the validation of the 21-day fish screening assay for the detection of endocrine substances (phase 1b), series on testing and assessment, Number 61, ENV/JM/MONO(2006)29. From http://www.oecd.org/dataoecd/.
OECD. (2007). Guidance document on the validation of (quantitative) structure-activity relationships [(Q)SAR] models. ENV/JM/MONO(2007)2. From http://www.oecd.org/dataoecd/.
OECD 210. (1992). OECD guideline for testing of chemicals. Test No. 210: Fish, early life stage toxicity test. From http://www.oecd.org/dataoecd/.
Owen, S. F., Giltrow, E., Huggett, D. B., Hutchinson, T. H., Saye, J., Winter, M. J., et al. (2007). Comparative physiology, pharmacology and toxicology of β-blockers: Mammals versus fish. Aquatic Toxicology, 82, 145-162.
Reinstorf, F., Strauch, G., Schirmer, K., Glaser, H. R., Moder, M., Wennrich, R., et al. (2008). Mass fluxes and spatial trends of xenobiotics in the waters of the city of Halle, Germany. Environmental Pollution, 152, 452-460.
Sanderson, H., Johnson, D. J., Wilson, C. J., Brain, R. A., & Solomon, K. R. (2003). Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicology Letters, 144, 383-395.
Sanderson, H., & Thomsen, M. (2007). Ecotoxicological quantitative structure-activity relationships for pharmaceuticals. Bulletin of Environmental Contamination and Toxicology, 79, 331-335.
Schirmer, M., Reinstorf, F., Leschik, S., Musolff, A., Krieg, R., Osenbrück, S., Martienssen, Schirmer, K. & Strauch, G. (2009). Transport and Fate of Xenobiotics in the Urban Water Cycle: Studies in Halle/Saale and Leipzig (Germany). In: Xenobiotics in the Urban Water Cycle: Mass Flows, Environmental Processes and Mitigation Strategies (Kassinos, F. et al., eds.), Springer.
Scholz, S., Fischer, S., Gündel, U., Küster, E., Luckenbach, T., & Voelker, D. (2008). The zebrafish embryo model in environmental risk assessment - applications beyond acute toxicity testing. Environmental Science and Pollution Research, 15, 394-404.
Scholz, S., & Mayer, I. (2008). Molecular biomarkers of endocrine disruption in small model fish. Molecular and Cellular Endocrinology, 293, 57-70.
Schwaiger, J., Ferling, H., Mallow, U., Negele, R. D., & Wintermayr, H. (2004). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology, 68, 141-150.
Seiler, J. P. (2002). Pharmacodynamic activity of drugs and ecotoxicology - can the two be connected? Toxicology Letters, 131, 105-115.
Strauch, G., Möder, M., Wennrich, R., Osenbrück, K., Gläser, H.-R., Schladitz, T., et al. (2008). Indicators for assessing anthropogenic impact on urban surface and groundwater. Journal of Soil and Sediments, 8, 23-33.
Sumpter, J. P. (2007). Environmental effects of human pharmaceuticals. Drug Information Journal, 41, 143-147.
Ternes, T. A., Joss, A., & Sigriest, H. (2004). Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology, 38, 338A-352A.
Tyler, C. R., Jobling, S., & Sumpter, J. P. (1998). Endocrine disruption in wildlife: A critical review of the evidence. Critical Reviews in Toxicology, 28, 319-361.
USEPA. (2007). Validation of the fish short-term reproduction assay: Integrated summary report. U.S. Environmental Protection Agency, Endocrine Disruptor Screening Program. From http:// www.epa.gov/EPA-PEST/2007.
van der Jagt, K., Munn, S., Torslov, J., & de Bruijn, J. (2004). Alternative approaches can reduce the use of test animals under REACH. Addenddum to the report: Assessment of additional testing needs under REACH - Effects of (Q)SARS, risk based testing and voluntary industry initiatives. Commission of the European Union. EUR 21405 EN. From http://ecb.jrc.ec.europa.eu/documents/REACH/PUBLICATIONS.
van der Ven, K., Keil, D., Moens, L. N., Van Leemput, K., Van Remortelt, P., & De Coen, W. M. (2006). Neuropharmaceuticals in the environment: Mianserin-induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays. Environmental Toxicology and Chemistry, 25, 2645-2652.
Vedani, A., Spreafico, M., Peristera, O., Dobler, M., & Smiesko, M. (2008). VirtualToxLab - in silico prediction of the endocrine-disrupting potential of drugs and chemicals. Chimia, 62, 322-328.
Weil, M., Sacher, F., Scholz, S., Zimmer, M., Nagel, R., & Duis, K. (2009). Gene expression analysis in zebrafish embryos - a potential approach to predict effect concentrations in the fish early life stage test. Environmental Toxicology and Chemistry 28, 1970-1978.
Yang, L., Kemadjou, J., Zinsmeister, C., Bauer, M., Legradi, J., Müller, F., et al. (2007). Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biology, 8, R227.
Zwiener, C., Glauner, T., & Frimmel, F. H. (2000). Biodegradation of pharmaceutical residues investigated by SPE- GC/ITD-MS and on-line derivatization. Hrc-Journal of High Resolution and Chromatography, 23, 474-478.
Acknowledgements
We acknowledge the support by the Helmholtz Centre for Environmental Research - UFZ for the integrated project “Risks of micro-pollutants in water and soil in the urban environment - biologic effects of new emerging compounds”.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Scholz, S., Schirmer, K., Altenburger, R. (2010). Pharmaceutical Contaminants in Urban Water Cycles: A Discussion of Novel Concepts for Environmental Risk Assessment. In: Fatta-Kassinos, D., Bester, K., Kümmerer, K. (eds) Xenobiotics in the Urban Water Cycle. Environmental Pollution, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3509-7_13
Download citation
DOI: https://doi.org/10.1007/978-90-481-3509-7_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3508-0
Online ISBN: 978-90-481-3509-7
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)